Security Name | Ticker | % of Net Assets |
---|---|---|
ABBVIE INC | ABBV | 6.95% |
AMGEN INC. | AMGN | 4.77% |
GILEAD SCIENCES, INC. | GILD | 4.77% |
VERTEX PHARMACEUTICALS | VRTX | 3.98% |
CORTEVA INC | CTVA | 3.65% |
ALNYLAM PHARMACEUTICALS | ALNY | 3.22% |
REGENERON PHARMACEUTICALS | REGN | 3.06% |
BEONE MEDICINES LTD-ADR | BGNE | 2.36% |
NATERA INC | NTRA | 2.35% |
ASTRAZENECA PLC ADR | AZN | 2.20% |
BIOGEN IDEC, INC. | BIIB | 2.03% |
ROYALTY PHARMA PLC- CL A | RPRX | 1.93% |
UNITED THERAPEUTICS CORP | UTHR | 1.88% |
NEUROCRINE BIOSCIENCES IN | NBIX | 1.77% |
EXACT SCIENCES | EXAS | 1.74% |
ILLUMINA INC | ILMN | 1.72% |
EXELIXIS, INC. | EXEL | 1.70% |
INSMED INC | INSM | 1.62% |
BLUEPRINT MEDICI | BPMC | 1.60% |
INCYTE CORP | INCY | 1.57% |
VIATRIS INC | VTRS | 1.49% |
BIOMARIN PHARMACEUTICAL | BMRN | 1.37% |
ARGENX SE - ADR | ARGX | 1.33% |
BIONTECH SE-ADR | BNTX | 1.31% |
GUARDANT HEALTH INC | GH | 1.30% |
MODERNA INC | MRNA | 1.30% |
BRIDGEBIO PHARMA INC | BBIO | 1.30% |
REVOLUTION MEDICINES INC | RVMD | 1.26% |
IONIS PHARMACEUTICALS, IN | IONS | 1.17% |
LEGEND BIOTECH CORP-ADR | LEGN | 1.14% |
HALOZYME THERAPEUTICS INC | HALO | 1.14% |
ALKERMES PLC | ALKS | 1.14% |
TG THERAPEUTICS | TGTX | 1.13% |
CRISPR THERAPEUTICS AG | CRSP | 1.11% |
JAZZ PHARMACEUTICALS PLC | JAZZ | 1.07% |
ADMA BIOLOGICS INC | ADMA | 1.06% |
ROIVANT SCIENCES LTD | ROIV | 1.05% |
MEDPACE HOLDINGS | MEDP | 0.98% |
ACADIA PHARMACEUTICALS IN | ACAD | 0.90% |
AXSOME THERAPEUT | AXSM | 0.88% |
AVIDITY BIOSCIENCES INC | RNA | 0.87% |
PROTAGONIST THER | PTGX | 0.85% |
SPRINGWORKS THERAPEUTICS | SWTX | 0.84% |
PTC THERAPEUTICS | PTCT | 0.83% |
ULTRAGENYX PHARM | RARE | 0.82% |
CYTOKINETICS INC | CYTK | 0.81% |
VIKING THERAPEUTICS INC | VKTX | 0.77% |
CRINETICS PHARMACEUTICALS | CRNX | 0.76% |
SUMMIT THERAPEUTICS INC | SMMT | 0.75% |
VAXCYTE INC | PCVX | 0.72% |
ARROWHEAD PHARMACEUTICALS | ARWR | 0.71% |
ASCENDIS PHA-ADR | ASND | 0.71% |
ARCELLX INC | ACLX | 0.70% |
IDEAYA BIOSCIENCES INC | IDYA | 0.68% |
VERACYTE INC | VCYT | 0.66% |
AGIOS PHARMACEUT | AGIO | 0.64% |
RECURSION PHARMACEUTICALS | RXRX | 0.64% |
DENALI THERAPEUT | DNLI | 0.62% |
NUVALENT INC-A | NUVL | 0.62% |
DYNE THERAPEUTICS INC | DYN | 0.60% |
APELLIS PHARMACE | APLS | 0.60% |
SAREPTA THERAPEU | SRPT | 0.57% |
TWIST BIOSCIENCE CORP | TWST | 0.56% |
BEAM THERAPEUTICS INC | BEAM | 0.54% |
CELLDEX THERAPEUTICS INC | CLDX | 0.53% |
AMICUS THERAPEUTICS INC | FOLD | 0.52% |
MADRIGAL PHARMAC | MDGL | 0.48% |
NOVAVAX INC | NVAX | 0.48% |
IMMUNOVANT INC | IMVT | 0.46% |
DYNAVAX TECHNOLOGY | DVAX | 0.46% |
INTELLIA THERAPE | NTLA | 0.40% |
KRYSTAL BIOTECH INC | KRYS | 0.40% |
IOVANCE BIOTHERAPEUTICS | IOVA | 0.30% |
GERON CORP | GERN | 0.30% |
Other (Cash, derivatives and other liabilities) | 0.50% | |
Total: |
Read a prospectus and summary prospectus (if available) carefully before investing. It contains the investment objective, risks charges, expenses and the other information, which should be considered carefully before investing. To obtain a prospectus and summary prospectus (if available) click here or call 800.820.0888.
Investing involves risk, including the possible loss of principal.
Guggenheim Investments represents the following affiliated investment management businesses of Guggenheim Partners, LLC: Guggenheim Partners Investment Management, LLC, Security Investors, LLC, Guggenheim Funds Distributors, LLC, Guggenheim Funds Investment Advisors, LLC, Guggenheim Corporate Funding, LLC, Guggenheim Wealth Solutions, LLC, Guggenheim Partners Europe Limited, Guggenheim Partners Japan Limited, GS GAMMA Advisors, LLC, and Guggenheim Private Investments, LLC.
© 2025 Guggenheim Investments. All Rights Reserved.
Research our firm with FINRA Broker Check.
• Not FDIC Insured • No Bank Guarantee • May Lose Value
This website is directed to and intended for use by citizens or residents of the United States of America only. The material provided on this website is not intended as a recommendation or as investment advice of any kind, including in connection with rollovers, transfers, and distributions. Such material is not provided in a fiduciary capacity, may not be relied upon for or in connection with the making of investment decisions, and does not constitute a solicitation of an offer to buy or sell securities. All content has been provided for informational or educational purposes only and is not intended to be and should not be construed as legal or tax advice and/or a legal opinion. Always consult a financial, tax and/or legal professional regarding your specific situation. Investing involves risk, including the possible loss of principal.